![](/img/cover-not-exists.png)
Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens
Goffin, J. R., Nicholas, G., Mates, M., Tu, D., Chen, E., Laurie, S. A., Juergens, R., Robinson, A., Goss, G., Reaume, M., Sun, S., Christink, K., Maize, C., MacFarlan, S., Sun, X., Ritter, H., SeymouLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0680-z
Date:
October, 2018
File:
PDF, 483 KB
english, 2018